Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | BRD2 | P25440 | 1/20 | 0.32 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.31 |
| ▸ | FADS1 | O60427 | 2/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19345023 | 0.90 | HRH3 (0.40) | HRH3BRD4BRD2BRD3PGR | |
| SCHEMBL19340270 | 0.89 | FADS1 (0.32) | BRD4CYP19A1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL19344951 | 0.87 | FADS1 (0.36) | BRD4FADS1GRM5 | |
| SCHEMBL19345003 | 0.86 | ALDH1A1 (0.37) | HRH3BRD4FAAHMGLLPGR | |
| SCHEMBL19344971 | 0.85 | ELANE (0.41) | HRH3BRD4PGR | |
| SCHEMBL19345029 | 0.84 | MEN1 (0.34) | HRH3CYP19A1FAAHMGLLSLC6A2 | |
| SCHEMBL19345072 | 0.81 | PGR (0.35) | CYP19A1PGR | |
| SCHEMBL19344998 | 0.81 | STS (0.41) | CYP19A1PGR | |
| SCHEMBL19344975 | 0.78 | PGR (0.44) | PGR | |
| SCHEMBL19344977 | 0.78 | FAAH (0.35) | HRH3CYP19A1FAAHMGLLSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2017-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | OR10J3, RPS10, OR51E2 | HRH3 220/4885BRD4 1859/4885BRD2 2653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.